<DOC>
	<DOCNO>NCT02416687</DOCNO>
	<brief_summary>The etonogestrel ( ENG ) implant insert immediately postpartum reduces risk pregnancy recurrence , especially vulnerable population . A limitation recommend practice universally low quality evidence effect ENG implant breastfeeding insert immediately postpartum . This study first assess impact insert ENG implant immediately postpartum amount milk use gold standard method purpose .</brief_summary>
	<brief_title>Etonogestrel Implant Postpartum Insertion</brief_title>
	<detailed_description>What know already : The ENG implant insert immediately postpartum reduces risk pregnancy recurrence , especially vulnerable population . A limitation recommend practice universally low quality evidence effect ENG implant breastfeeding insert immediately postpartum . This study first assess impact insert ENG implant immediately postpartum amount milk use gold standard method purpose . Study design , size , duration : This randomize , single-blind control clinical trial evaluate 24 postpartum woman NBs conduct Women 's Health Reference Center Ribeirão Preto , Brazil . The mother-NB pair evaluate six week postpartum . Participants/materials , set , method : Twenty-four mother-NB pair randomize two group : ) Implant group : ENG-releasing implant insert within 48 h delivery b ) Control group : absence contraceptive method six week delivery . Anthropometric assessment breastfeed questionnaire conduct 4-time point 6-week monitoring period ( study admission 14th , 29th 43rd day randomization ) . Saliva sample collect mother-NB pair prior deuterium ( D2O ) dose administration . Totals 5 g 10 g D2O orally administer postpartum woman day randomization ( day 0 ) 29th study day , respectively . New saliva sample collect day 1 , 2 , 3 , 4 , 13 14 follow intake D2O dose . The D2O isotope ratio assess saliva sample use mass spectrometry estimate volume breast milk ingest NB ( daily average express mL/day ) .</detailed_description>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<criteria>Postpartum woman age 18 year old agree use ENG implant contraceptive method , Body mass index ( BMI ) &lt; 30 kg/m2 , Women without contraindication breastfeeding , Women whose newborn healthy , without malformation , born term ( gestational age ≥ 37 week ) , appropriate weight gestational age normal suck ability , include . The subject live Ribeirão Preto breastfed child previous delivery least 3 month . Tobacco smoker , drug addict alcoholic , Women educational level low 5 year , Women clinical condition consider category 3 4 implant use ( except insertion immediately postpartum ) WHO ( World Health Organization , 2009 ) , Women histories psychiatric illness , Women use medication could alter concentration etonogestrel , Women know allergy local anesthetic lidocaine ( used place implant ) , Women want keep cyclic menstrual bleeding</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>